|
|
DSpace at RU >
Browsing by Author Gratwohl, A.
Showing results 1 to 26 of 26
| Full Text | Issue Date | Title | Author(s) | | 2012 | Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. | Garderet, L.; Iacobelli, S.; Moreau, P.; Dib, M.; Lafon, I., et al |
| 2012 | The EBMT activity survey: 1990-2010. | Passweg, J.R.; Baldomero, H.; Gratwohl, A.; Bregni, M.; Cesaro, S., et al |
| 2012 | Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. | Ruutu, T.; Biezen, A. van; Hertenstein, B.; Henseler, A.; Garderet, L., et al |
| 2011 | The European LeukemiaNet: achievements and perspectives | Hehlmann, R.; Grimwade, D.; Simonsson, B.; Apperley, J.; Baccarani, M., et al |
| 2011 | Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation | Gratwohl, A.; Brand, R.; Niederwieser, D.; Baldomero, H.; Chabannon, C., et al |
| 2011 | Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation | Michallet, M.; Dreger, P.; Sutton, L.; Brand, R.; Richards, S., et al |
| 2010 | Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT. | Koenecke, C.; Hertenstein, B.; Schetelig, J.; Biezen, A. van; Dammann, E., et al |
| 2010 | Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial. | Witte, T.J.M. de; Hagemeijer, A.; Suciu, S.; Belhabri, A.; Delforge, M., et al |
| 2010 | Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia. | Dickinson, A.M.; Pearce, K.F.; Norden, J.; O'Brien, S.G.; Holler, E., et al |
| 2010 | Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. | Ljungman, P.; Bregni, M.; Brune, M.; Cornelissen, J.; Witte, T.J.M. de, et al |
| 2009 | Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation. | Kroger, N.; Brand, R.; Biezen, A. van; Zander, A.; Dierlamm, J., et al |
| 2009 | Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. | Gratwohl, A.; Stern, M.; Brand, R.; Apperley, J.; Baldomero, H., et al |
| 2008 | Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. | Stern, M.; Brand, R.; Witte, T.J.M. de; Sureda, A.; Rocha, V., et al |
| 2006 | The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes. | Witte, T.J.M. de; Brand, R.; Biezen, A. van; Delforge, M.; Biersack, H., et al |
| 2005 | Autologous hematopoietic stem cell transplantation for autoimmune diseases. | Gratwohl, A.; Passweg, J.R.; Bocelli-Tyndall, C.; Fassas, A.; Laar, J.M. van, et al |
| 2004 | Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. | Farge, D.; Passweg, J.R.; Laar, J.M. van; Marjanovic, Z.; Besenthal, C., et al |
| 1997 | European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia : Impact of HLA class II matching | Devergie, A.; Apperley, J.; Labopin, M.; Madrigal, A.; Jacobsen, N., et al |
| 1997 | Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation | Rhee, F. van; Szydlo, R.M.; Hermans, J.; Devergie, A.; Frassoni, F., et al |
| 1997 | Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS | Witte, T.J.M. de; Biezen, A. van; Hermans, J.; Labopin, M.; Runde, V., et al |
| 1997 | A european perspective on haematopoietic growth factors in haemato-oncology : report of an expert meeting of the EORTC | Croockewit, A.J.; Bronchud, M.H.; Aapro, M.S.; Bargetzi, M.; Crown, J., et al |
| 1996 | Results of allogeneic bone marrow transplantation for aucte leukemia have improved in Europe with time - a report of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) | Frassoni, F.; Labopin, M.; Gluckman, E.; Prentice, H.G.; Vernant, J.P., et al |
| 1996 | Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia | Gratwohl, A.; Hermans, J.; Biezen, A. van; Arcese, W.; Debusscher, L., et al |
| 1995 | An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors | Gahrton, G.; Tura, S.; Ljungman, P.; Blade, J.; Cavo, M., et al |
| 1995 | Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma | Gahrton, G.; Tura, S.; Ljungman, P.; Bladé, J.; Brandt, L., et al |
| 1995 | Nieuwe ontwikkelingen in de therapie van het myelodysplastisch syndroom | Witte, T.J.M. de; Hermans, J.; Biezen, A. van; Runde, V.; Gratwohl, A. |
| 1995 | Acute Graft-versus-Host disease : grade and outcome in patients with chronic myelogenous leukemia | Gratwohl, A.; Hermans, J.; Apperley, J.; Arcese, W.; Bacigalupo, A., et al |
Showing results 1 to 26 of 26
|